◆ 会议时间：2023年3月2日至3日
◆ 会议地点：美国 华盛顿（Washington, DC）

◆ 会议简介：

2023年美国血液学会(ASH)血液病免疫疗法峰会将于2023年3月2日至3日在美国华盛顿举行，会议由美国血液学会(ASH)主办。通过参加本次会议，与会者可以：了解免疫疗法的现状及其在血液系统疾病中的应用；深入了解联合疗法在血液疾病治疗中的应用；了解免疫疗法在临床实践中的监管和实施；更好地了解利用细胞疗法治疗非恶性和病毒相关血液病；讨论对后期免疫治疗临床试验设计至关重要的科学、临床和监管方面的问题；等等。

美国血液学会（ASH）成立于1958年，是世界上最大的关注血液疾病病因与治疗的专业学会，在全球近100个国家拥有超过17,000名成员，ASH为世界各地致力于治疗血液疾病的临床医生和科学家服务。ASH通过促进宣对血液学的研究、临床护理、教育、培训和宣传，进而促进对血液、骨髓、免疫、止血和血管系统疾病的了解、诊断与防治。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）

American Society of Hematology (ASH) Summit on Immunotherapies for Hematologic Diseases 2023
Date: March 2-3, 2023
Venue: Omni Shoreham, Washington, DC, USA

Why is the success of immunotherapies and other targeted therapies such as gene therapy so variable within different patient populations? How can we improve these targeted therapies for widespread use in patients with hematologic diseases? Help answer these questions and more at the ASH Summit on Immunotherapies for Hematologic Diseases.

This in-person Summit is a unique meeting of the minds among the academic, medical, industry, and federal regulatory communities to address the obstacles in immunotherapy treatment development for non-malignant and malignant hematologic conditions. Whether you’re a career or trainee researcher or clinician, industry professional, or federal regulator, you won’t want to miss this unique opportunity to share ideas! Through participation in this meeting, attendees will be able to:

• Discuss fundamental advances in basic immunology that provide the foundation for immune therapies and their application
• Gain insights into critical limitations of immunotherapies and gene therapy including associated adverse events
• Examine cellular and molecular mechanisms involved in resistance and relapse associated with these therapies
• Review new immunotherapy targets
• Discuss the application of CRISPR gene editing in the development of targeted therapies
• Analyze cell manufacturing considerations
• Learn about the application of immunotherapies for the treatment of both non-malignant hematologic and malignant diseases

Target Audience

The ASH Summit on Immunotherapies for Hematologic Diseases is designed to provide a wide set of learning and networking opportunities for experts in hematology, including:

• Laboratory-based scientists
• Translational and clinical researchers
• Practitioners interested in the application of immunotherapies
• Young investigators (trainees)
• Cellular therapy, gene therapy, biopharmaceutical, and life sciences industry experts
• Regulatory scientists

摘要征文投稿：

Abstracts may now be submitted to the ASH Summit on Immunotherapies for Hematologic Diseases through ASH's online abstract submission system(点此提交). The submission deadline is Thursday, January 5, 2023 at 11:59 p.m. Pacific time.

There is a $60 nonrefundable handling fee for submitting an abstract. 

注册费：

REGISTRATION CATEGORIES AND FEES

1You must be a member at the time of registration to receive this rate. Applicants approved for membership after registering for the meeting will not be refunded the difference between the member and non-member rates.

2Non-members in training must provide an original letter on their institution’s letterhead, signed by a training program director, which states that they are currently enrolled in a training program. After you complete the registration process, an email will automatically be sent to your program director or school counselor requesting a signed verification letter on official letterhead confirming that you are a trainee. This verification letter is required and should be uploaded in PDF format using the link provided in the email. Your registration will not be official until ASH confirms your training status. If you registered in the non-member in training category last year and are still enrolled in the same training program, you do NOT need to send a letter verifying your enrollment status.

3The allied health professional category is for individuals without a doctoral degree who provide direct patient care. Individuals with an MD, PhD, or PharmD degree do not qualify for this category because they are eligible for ASH membership. These individuals should register in the member or non-member category based upon their current membership status. All ASH members receive discounted rates at the Summit on Immunotherapies.

Your registration fee includes:

• Access to all meeting sessions, panel discussions, networking breaks, and exhibits
• Access to the Highlights of ASH mobile app

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。